Song, Santai External Author

Publications

Sort by

Selected publications

  • 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): An open-label, randomised controlled trialAmerican Society of Mechanical Engineers, Bioengineering Division (Publication) BED2013 Academic Article GET IT
    Times cited: 211